compound semaglutide news compounding fda FDA moves to stop compounding GLP-1 drugs Compounded versions of weight loss – Semaglutide: Compounding pharmacies to end

GLP-1 Receptor Stimulation Preserves Primary Cortical and Dopaminergic Neurons in Cellular and Rodent Models of Stroke and Parkinsonism

Chloroplast signaling and LESION SIMULATING DISEASE1 regulate crosstalk between light acclimation and immunity in Arabidopsis

These drugs are becoming increasingly accessible, and it is concerning that, in some cases, people can simply go online and order these kinds of medications when they may not have a full understanding of what could potentially happen

Without clear guardrails, the promise of empowerment risks devolving into a subscription model of self-monitoring, where the metric of success is not patient health, but user retention